Overactive Bladder Syndrome: Considerations in Pharmacotherapy and New Perspectives

Publisher： Karger

E-ISSN： 1423-0011|46|3|83-87

ISSN： 1018-8843

Source： Gynäkologisch-geburtshilfliche Rundschau, Vol.46, Iss.3, 2006-06, pp. : 83-87

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment options for the overactive bladder syndrome

By Hashim Hashim   Abrams Paul  

Therapy, Vol. 2, Iss. 6, 2005-11 ,pp. : 921-936

Future Medicine

Access to resources Recommend Favorite

Evaluation of Sexual Function in Women with Overactive Bladder Syndrome

By  

Urologia Internationalis, Vol. 78, Iss. 2, 2007-02 ,pp. : 112-115

Karger

Access to resources Recommend Favorite

Stimulus‐associated urinary urges in overactive bladder syndrome

By  

NEUROUROLOGY AND URODYNAMICS, Vol. 37, Iss. 1, 2018-01 ,pp. : 284-290

John Wiley & Sons Inc

Access to resources Recommend Favorite

Overactive Bladder Syndrome, Detrusor Overactivity and the Botulinum Toxin

By  

Reviews on Recent Clinical Trials, Vol. 10, Iss. 2, 2015-01 ,pp. : 128-134

Bentham Science Publishers

Access to resources Recommend Favorite

The management of overactive bladder syndrome: a review of the European Association of Urology Guidelines

By Osman Nadir I   Chapple Christopher R  

Clinical Practice, Vol. 10, Iss. 5, 2013-09 ,pp. : 593-606

Future Medicine

Access to resources Recommend Favorite